• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

LifeShield announces agreement to acquire IAC, an Oklahoma City-based insurance company

Share:

June 10, 2019

LifeShield National Insurance Co. announced that it has entered an agreement to acquire IAC Group, the parent company of Individual Assurance Company, a leading life, accident, and health insurer with a strong presence in the Medicare supplement market. The agreement has been unanimously approved by the boards of LifeShield and IAC Group. Following the transaction, IAC will continue to operate under the IAC brand as a subsidiary of LifeShield.

Upon announcing the transaction, David Brooks, President of LifeShield, said, “This is a unique opportunity for LifeShield to enhance its operational capabilities, and will enable both companies to become leading providers of products in the senior market. The transaction offers significant long-term value for LifeShield by adding new products and lower operating expenses. Combining the operations will enable both companies to execute in the individual, worksite, and association market space, including life, Medicare supplement, accident and health specialty lines, and reinsurance.”

Mr. Brooks continued, “I am excited about adding IAC’s experienced and proven team, as it will help LifeShield to further capitalize on opportunities created through recent product and distribution initiatives, while giving LifeShield access to the innovative client solutions IAC has developed. We were attracted to IAC in large part because both companies share a culture focused on people, risk management, and innovation. This combination will position both LifeShield and IAC for the evolving future of the insurance industry.”

Jim Harlin, chairman and CEO of IAC, added, “This is an attractive combination of Oklahoma domestic life and health insurers with highly complementary businesses and operations, and I’m thrilled with the platform for continued success that this transaction creates for our organizations.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Upon completion of the transaction, IAC Group will operate as a subsidiary of LifeShield and will be led by David Brooks, President of LifeShield. Following the closing, Jim Harlin, IAC’s current chairman and CEO, will serve as a consultant to IAC, advising on integration-related matters and other strategic opportunities. All employees of IAC will continue with the company following the acquisition.

Completion of the transaction is subject to customary closing conditions, including the receipt of required regulatory approvals.

LifeShield was advised by John Tiller as financial and actuarial advisor and Hartzog Conger Cason as legal counsel. IAC was advised by DeBee Clark as legal counsel.

Date: June 10, 2019

Source: Cision

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Regeneron’s CEO says We Could Have a Covid-19 TreatmentRegeneron’s CEO says We Could Have a Covid-19 Treatment
  • Zimmer Biomet Completes Acquisition of A&E Medical CorporationZimmer Biomet Completes Acquisition of A&E Medical Corporation
  • New Report Examines the Rise of Digital Decentralised Clinical Trial TechnologyNew Report Examines the Rise of Digital Decentralised Clinical Trial Technology
  • Hong Kong-Based AI Developer Creates COVID-19 Survival CalculatorHong Kong-Based AI Developer Creates COVID-19 Survival Calculator
  • Accolade Acquires Virtual Primary Care Platform PlushCareAccolade Acquires Virtual Primary Care Platform PlushCare
  • Iktos and Almirall Announce Research Collaboration in Artificial Intelligence for New Drug DesignIktos and Almirall Announce Research Collaboration in Artificial Intelligence for New Drug Design
  • Takeda gets Japanese approval for $62 billion Shire purchaseTakeda gets Japanese approval for $62 billion Shire purchase
  • Femtech Markets Look Beyond Fertility, According to New ReportFemtech Markets Look Beyond Fertility, According to New Report

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications